Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
JCO Oncology Practice|May 23, 2023
On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black VeteransJeffrey W Shevach, Lisa B Aiello, Julie A Lynch, et al.
The New England Journal of Medicine|August 6, 2015
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerChristopher J Sweeney, Yu-Hui Chen, Michael Carducci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancerMichael J Hassett, Samuel M Silver, Melissa E Hughes, et al.
The Oncologist|November 30, 2017
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access ProgramOliver Sartor, Nicholas J Vogelzang, Christopher Sweeney, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 20, 2013
Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational modelSharon Manne, Deborah Kashy, Terrance Albrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsNeal J Meropol, Yu-Ning Wong, Terrance Albrecht, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2011
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failureNizar M Tannir, Yu-Ning Wong, Christian K Kollmannsberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Financial Concerns About Participation in Clinical Trials Among Patients With CancerYu-Ning Wong, Mark D Schluchter, Terrance L Albrecht, et al.
The Oncologist|May 3, 2023
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate CancerRavi A Madan, Marijo Bilusic, Mark N Stein, et al.
Pageof 14